跳至主要内容
临床试验/ITMCTR2100004437
ITMCTR2100004437招募中3 期

Efficacy and Safety of Tanreqing Oral Liquid in Treatment of Acute Bronchitis (Phlegm-Heat Obstructing Lungs Syndrome): a multicenter, randomized, double-blind, placebo-controlled trial

West China Hospital, Sichuan University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. Diagnosis of acute trachea-bronchitis;
  • 2. Phlegm-heat obstructing lungs syndrome in traditional Chinese medicine 'Zheng';
  • 3. Total cough symptom score >=4 points;
  • 4. Expectoration in traditional Chinese medicine symptom score >=6 points;
  • 5. Bronchitis severity score>=6 points;
  • 6. Disease course within 72 hours;
  • 7. Aged 18 to 65 years old;
  • 8. Voluntarily provide written and informed consent.

排除标准

  • 1. Patients with respiratory diseases such as chronic obstructive pulmonary disease, bronchiectasis, asthma, lung cancer, tuberculosis, pneumonia, lung abscess and chest X-ray showing lung inflammation lesions;
  • 2. Patient with severe underlying cardiac, cerebral, hematological, hepatic or renal disorders or other diseases significantly affecting the survival and prognosis, such as cancer;
  • 3. Current smokers or recent ex-smokers quitting smoking less than 1 month ago;
  • 4. Use of an angiotensin-converting-enzyme inhibitor in the last 1 month
  • 5. Patients with body temperature>=38.5 degree C;
  • 6. ALT or AST>1.5 ULN, urine protein>+, serum creatine abnormality, white blood cell count<3x10^9/L or >10x10^9/L, and or neutrophil granulocyte>80%, or those who need antibiotic therapy;
  • 7. Those who have used other medicines after disease onset including antibiotics, expectorants, antitussives, systemic or inhaled corticosteroids, inhaled bronchodilators, Chinese medicines of relieving exterior syndrome with pungent-cool drugs, clearing away heat and detoxification and other related Chinese medicines;
  • 8. Pregnant or lactating women and those who have pregnancy plans in the last 3 months;
  • 9. Allergic constitution or known to be allergic to any ingredients in tested drug;
  • 10. Mental patients or legal disability;
  • 11. Patients who have participated or are currently participating in another clinical trial in the last one month;
  • 12. Patients who are inappropriate for participation judged by researchers.

研究者

发起方
West China Hospital, Sichuan University

相似试验